The anti-inflammatory effect of ε-viniferin by specifically targeting formyl peptide receptor 1 on human neutrophils

Chem Biol Interact. 2021 Aug 25:345:109490. doi: 10.1016/j.cbi.2021.109490. Epub 2021 Jun 16.

Abstract

The uncontrol respiratory burst in neutrophils can lead to inflammation and tissue damage. This study investigates the effect and the underlying mechanism of ε-viniferin, a lignan from the root of Vitis thunbergii var. thunbergii, inhibits N-formyl-L-methionyl-L-leucyl-l-phenylalanine (fMLP) induced respiratory burst by antagonizing formyl peptide receptor 1 in human neutrophils. Briefly, ε-viniferin specifically inhibited fMLP (0.1 μM: formyl peptide receptor 1 agonist or 1 μM: formyl peptide receptor 1, 2 agonist)-induced superoxide anion production in a concentration-dependent manner (IC50 = 2.30 ± 0.96 or 9.80 ± 0.21 μM, respectively) without affecting this induced by formyl peptide receptor 2 agonist (WKYMVM). ε-viniferin inhibited fMLP (0.1 μM)-induced phosphorylation of ERK, Akt, Src or intracellular calcium mobilization without affecting these caused by WKYMVM. The synergistic suppression of fMLP (1 μM)-induced superoxide anion production was observed only in the combination of ε-viniferin and formyl peptide receptor 2 antagonist (WRW4) but not in combination of ε-viniferin and formyl peptide receptor 1 antagonist (cyclosporine H). ε-viniferin inhibited FITC-fMLP binding to formyl peptide receptors. Moreover, the synergistic suppression of FITC-fMLP binding was observation only in the combination of ε-viniferin and WRW4 but not in other combinations. ATPγS induced superoxide anion production through formyl peptide receptor 1 in fMLP desensitized neutrophils and this effect was inhibited by ε-viniferin. The concentration-response curve of fMLP-induced superoxide anion was not parallel shifted by ε-viniferin. Furthermore, the inhibiting effect of ε-viniferin on fMLP-induced superoxide anion production was reversible. These results suggest that ε-viniferin is an antagonist of formyl peptide receptor 1 in a reversible and non-competitive manner.

Keywords: Formyl-peptide receptors; Neutrophil; Vitis thunbergii var. thunbergii; fMLP; ε-viniferin.

MeSH terms

  • Amino Acid Sequence
  • Anti-Inflammatory Agents / pharmacology*
  • Benzofurans / pharmacology*
  • Calcium / metabolism
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Humans
  • Molecular Targeted Therapy*
  • Neutrophils / drug effects*
  • Neutrophils / metabolism*
  • Oligopeptides / chemistry
  • Oligopeptides / pharmacology
  • Receptors, Formyl Peptide / antagonists & inhibitors*
  • Stilbenes / pharmacology*
  • Superoxides / metabolism

Substances

  • Anti-Inflammatory Agents
  • Benzofurans
  • FPR1 protein, human
  • Oligopeptides
  • Receptors, Formyl Peptide
  • Stilbenes
  • Superoxides
  • epsilon-viniferin
  • Calcium